African Journal of
Bacteriology Research

  • Abbreviation: J. Bacteriol. Res.
  • Language: English
  • ISSN: 2006-9871
  • DOI: 10.5897/JBR
  • Start Year: 2009
  • Published Articles: 120

Full Length Research Paper

Contribution of COVID-19 diagnosis in patients seen at the tuberculosis laboratory in the response to the COVID-19 pandemic in the Kayes Heath district

Maiga A.
  • Maiga A.
  • Laboratory of Medical Biology and Hospital Hygiene, Point-G University Hospital, Bamako, Mali.
  • Search for this author on:
  • Google Scholar
Cisse A. B.
  • Cisse A. B.
  • National Institute of Public Health, Bamako, Mali
  • Search for this author on:
  • Google Scholar
Soumano I.
  • Soumano I.
  • Kayes Reference Health Center, Mali.
  • Search for this author on:
  • Google Scholar
Ag. Baraika M.
  • Ag. Baraika M.
  • Laboratory of Chemistry, Faculty of Pharmacy (FAPH), University of Sciences, Technics and Technologies of Bamako (USTTB), Bamako, Mali.
  • Search for this author on:
  • Google Scholar
Sangare A. K.
  • Sangare A. K.
  • Charles Merieux Infectiology Center, Bamako, Mali.
  • Search for this author on:
  • Google Scholar
Diarra B.
  • Diarra B.
  • Faculty of Medicine and Odontostomatology, University of Sciences, Technics and Technologies of Bamako (USTTB), Bamako, Mali.
  • Search for this author on:
  • Google Scholar
Traore B.
  • Traore B.
  • Charles Merieux Infectiology Center, Bamako, Mali.
  • Search for this author on:
  • Google Scholar
Traore A.
  • Traore A.
  • National Institute for Training in Health Sciences, Bamako, Mali.
  • Search for this author on:
  • Google Scholar
Hamidou A
  • Hamidou A
  • Kayes Reference Health Center, Mali.
  • Search for this author on:
  • Google Scholar
Samake H
  • Samake H
  • National Institute of Public Health, Bamako, Mali.
  • Search for this author on:
  • Google Scholar
Maiga I. I.
  • Maiga I. I.
  • Laboratory of Medical Biology and Hospital Hygiene, Point-G University Hospital, Bamako, Mali.
  • Search for this author on:
  • Google Scholar
Guindo I.
  • Guindo I.
  • Laboratory of Chemistry, Faculty of Pharmacy (FAPH), University of Sciences, Technics and Technologies of Bamako (USTTB), Bamako, Mali.
  • Search for this author on:
  • Google Scholar


  •  Received: 05 January 2024
  •  Accepted: 09 February 2024
  •  Published: 31 March 2024

References

Adusi-Poku Y, Wagaw ZA, Frimpong-Mansoh RP, Asamoah IO, Sorvor F, Afutu FK, Sarpong C, Amoussou-Gohoungo LO, Abdulai FN, Ahmedov S (2023). Bidirectional screening and testing for TB and COVID-19 among outpatient department attendees: outcome of an initial intervention in Ghana. BMC Infectious Diseases 23(1):1-7.
Crossref
 

Chahboune M, Barkaoui M, Iderdar Y, Alwachami N, Mourajid Y, Ifleh M, Boumendil K, Bachar K, El Madani S (2022). Profil épidémiologique, aspects diagnostiques et évolutifs des patients tuberculeux au centre de diagnostic de la tuberculose et des maladies respiratoires de Settat, Maroc. The Pan African Medical Journal 42 p.
Crossref

  
 

Gidado M, Odume B, Ogbudebe C, Useni S, Tukur M, Chukwuogo O, Ajiboye P, Sadiq I, Yahaya K, Adebola L (2020). Early experience in implementation of an integrated COVID-19 and TB community-based active case finding in Nigeria. African Journal of Respiratory Medicine 15(2):18.
Crossref

  
 

Guirelli AO, Bispo TR, Colpas DR, de Campos IB, Chimara E, Cergole-Novella MC, Rodart IF, dos Santos Candido V, Segura-Ramírez PJ, Dos Santos Menezes Gaiotto Daros V, dos Santos Carmo AM (2022). Tuberculosis/COVID-19 co-infection detected in a single sputum sample using a rapid molecular test. Brazilian Journal of Microbiology 53(2):633-639.
Crossref

  
 

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet 395(10223):497-506.
Crossref

  
 

Kayali S, Karacorlu FN, Yilmaz M, Toraman ZA, Pirincci E (2022). Clinical Characteristics of COVID-19 in Active or Previously Treated Tuberculosis Patients in Turkey. Medical Bulletin of Haseki/Haseki Tip Bulteni 60(5):453-460.
Crossref

  
 

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, Bi Y (2020). Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet 395(10224):565-574.
Crossref

  
 

Luke E, Swafford K, Shirazi G, Venketaraman V (2022). TB and COVID-19: An Exploration of the Characteristics and Resulting Complications of Co-infection. Frontiers in bioscience (Scholar edition) 14(1):6.
Crossref

  
 

MacLean EL, Villa-Castillo L, Ruhwald M, Ugarte-Gil C, Pai M (2022). Integrated testing for TB and COVID-19. Med 3(3):162-166.
Crossref

  
 

Mao R, Qiu Y , HE J-S, Tan J'Y , Li XH, Liang J, Shen J, Zhu LR, Chen Y, Iacucci M, Ng SC, Ghosh S , Chen MH (2020). Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterology and Hepatology 5:667-668.
Crossref

  
 

Mahieu R (2020). Vincent Dubée. Caractéristiques cliniques et épidémiologiques de la Covid-19. Actualités Pharmaceutiques 59(599):24-26.
Crossref

  
 

Patel N, Kaur M, Aggarwal R, Ganesh V, Ayub A, Kumar R, Kodan P, Singh Y, Soni KD, Trikha A. (2023). Clinical characteristics, course and outcome of critically ill COVID-19 patients with previous or current TB admitted in ICU of a tertiary care COVID centre of Indian subcontinent. Lung India 40(1):91-93.
Crossref

  
 

Ren LL, Wang YM, Wu ZQ, Xiang ZC, Guo L, Xu T, Jiang YZ, Xiong Y, Li YJ, Li XW, Li H (2020). Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chinese Medical Journal 133(09):1015-1024.
Crossref

  
 

Ruhwald M, Hannay E, Sarin S, Kao K, Sen R, Chadha S (2022). Considerations for simultaneous testing of COVID-19 and tuberculosis in high-burden countries. The Lancet Global Health 10(4):e465-e466.
Crossref

  
 

Sar?no?lu RC, Sili U, Eryuksel E, Yildizeli SO, Cimsit C, Yagci AK (2020). Tuberculosis and COVID-19: An overlapping situation during pandemic. The Journal of Infection in Developing Countries 14(7):721-725.
Crossref

  
 

Shah T, Shah Z, Yasmeen N, Baloch Z, Xia X (2022). Pathogenesis of SARS-CoV-2 and Mycobacterium tuberculosis coinfection. Frontiers in Immunology 13:909011.
Crossref

  
 

Sy KTL, Haw NJL, Uy J (2020). Previous and active tuberculosis increases risk of death and prolongs recovery in patients with COVID-19. Infectious Diseases 52(12):902-907.
Crossref

  
 

World Health Organization (WHO) (2021). Maladie à coronavirus 2019 (COVID-19): How does COVID-19 spread between people?. Disponible sur

View

  
 

World Health Organization (WHO) (2022). Tuberculosis deaths and disease increase during the COVID-19 pandemic. Global tuberculosis report 2022. Geneva: Licence: CC BY-NC-SA 3.0 IGO.

  
 

World Health Organization (WHO) (2023). Bulletin on outbreaks and other emergencies - week 10: 27 February to 5 March 2023 [Consulté le 7 mai, 2023] », Health Emergency Information and Risk Assessment P 23.

  
 

Yang J, Zhenga Y, Goua X, Pua K, Chena Z, Guoa Q, Jia R, Wang H, Wanga Y, Zhou Y (2020). Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. International Journal of Infectious Diseases 94:91-95.
Crossref

  

 

Copyright © 2024 Author(s) retain the copyright of this article.

This article is published under the terms of the Creative Commons Attribution License 4.0

Back to Vol. 16 No. 1
Back to articles
SUBSCRIBE TO RSS
SUBMIT MANUSCRIPT
CONFERENCES